The concentration of IL-17A and G-CSF (in addition to MPO, CCL11, and CCL4) in post-acute serum allowed to distinguish NMO from MS patients, which may be associated with the activity and differentiation of neutrophils and eosinophils chemotaxis [117]. The gene discussed is IL17A; the disease is myeloid sarcoma.